We haven’t quite decided yet if the redundancy of these earnings calls is a good thing or not, but as has been said before it is what it is. Novo Nordisk this morning followed this pattern with one exception, and note we did hoop on the call a little late but based on the earnings press release and the presentation they did NOT pull full year financial guidance. This either makes them brave or stupid we won’t know which until the year is over.
Other than that results were positively impacted due to COVID and stocking up. The . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.